Fernando Cagide
Porto, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Discovery of Novel Ligands for the Treatment of Cryptococcus neoformans Infection.
Journal: Archiv der Pharmazie
Published: March 11, 2026
Monoterpenoid-ciprofloxacin hybrids as a strategy to disrupt Staphylococcus aureus biofilms and overcome associated resistance.
Journal: Journal of advanced research
Published: January 06, 2026
Mitochondria-targeted antioxidant AntiOxBEN2 prevents metabolic dysfunction-associated steatotic liver disease (MASLD) by enhancing fatty acid oxidation and mitochondrial bioenergetics.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 08, 2025
Beneficial effect of AntiOxBEN2, a mitochondria-directed antioxidant, on maturation of bovine oocytes: Analysis of bioenergetics pathways and embryo production.
Journal: Theriogenology
Published: June 30, 2025
Antibacterial effects of novel quaternary ammonium and phosphonium salts against Staphylococcus aureus.
Journal: Journal of applied microbiology
Published: March 05, 2025
Sublethal Concentrations of 2C-I and 25I-NBOMe Designer Drugs Impact Caenorhabditis elegans Development and Reproductive Behavior.
Journal: International journal of molecular sciences
Published: January 09, 2025
Assisted Reproduction Technologies (ART): Impact of Mitochondrial (Dys)function and Antioxidant Therapy.
Journal: Animals : an open access journal from MDPI
Published: December 11, 2024
The role of mitochondrial dysfunction and calcium dysregulation in 2C-I and 25I-NBOMe-induced neurotoxicity.
Journal: Chemico-biological interactions
Published: November 18, 2024
The mitochondriotropic antioxidants AntiOxBEN2 and AntiOxCIN4 are structurally-similar but differentially alter energy homeostasis in human skin fibroblasts.
Journal: Biochimica et biophysica acta. Bioenergetics
Published: November 12, 2024
Discovery of a Potent, Selective, and Blood-Brain Barrier Permeable Non-nitrocatechol Inhibitor of Catechol-O-methyltransferase.
Journal: Journal of medicinal chemistry
Published: October 07, 2024
Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities.
Journal: European journal of medicinal chemistry
Published: May 30, 2024
Efficacy of Novel Quaternary Ammonium and Phosphonium Salts Differing in Cation Type and Alkyl Chain Length against Antibiotic-Resistant Staphylococcus aureus.
Journal: International journal of molecular sciences
Published: November 17, 2023
Last Updated: 09/26/2026